US FDA approves Roivant-Priovant's skin and muscle disease drug

Reports

5

Domains carrying it

5

First reported

28 August 2026

Latest report

31 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 28 August 2026US FDA approves Roivant-Priovant's skin and muscle disease drugreuters.com
2. 30 August 2026Roivant Sciences Ltd. (ROIV) Discusses FDA Approval of LISRAYA as First Oral Targeted ...seekingalpha.com
3. 31 August 2026US FDA approves Roivant-Priovant's skin and muscle disease drugpharma.economictimes.indiatimes.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults10 reports · 10 domains · 2 September 2026
• Regeneron Pharmaceuticals Announces FDA Approval of Pasatru for Adults With ...11 reports · 8 domains · 31 August 2026
• FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer59 reports · 51 domains · 5 September 2026
• FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder14 reports · 12 domains · 1 September 2026
• US FDA approves Replimune's skin cancer drug15 reports · 14 domains · 10 August 2026
• Pasatru's FDA Approval Puts Regeneron's Rare-Disease Playbook To The Test2 reports · 2 domains · 22 August 2026

◆ Share

◆ Evidence

5 reports · 5 domains

• US FDA approves Roivant-Priovant's skin and muscle disease drugpharma.economictimes.indiatimes.com · 31 August 2026
• Roivant Sciences Ltd. (ROIV) Discusses FDA Approval of LISRAYA as First Oral Targeted ...seekingalpha.com · 30 August 2026
• FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant's Biz Strategymedcitynews.com · 28 August 2026
• FDA green lights Priovant drug for rare skin diseasebiopharmadive.com · 28 August 2026
• US FDA approves Roivant-Priovant's skin and muscle disease drugreuters.com · 28 August 2026